SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Bracken Franklin (Last) (First) (Middle) 330 WEST 34TH STREET (Street) NEW YORK NY 10001 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 07/22/2020	3. Issuer Name and Ticker or Trading Symbol FOOT LOCKER, INC. [ FL ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive VP CEO North America	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	452	D
Common Stock	$8,508(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	03/26/2015(2)	08/26/2024	Common Stock	1,400	45.08	D
Employee Stock Option (right to buy)	03/25/2016(3)	03/25/2025	Common Stock	1,250	62.11	D
Employee Stock Option (right to buy)	03/23/2017(4)	03/23/2026	Common Stock	6,336	63.79	D
Employee Stock Option (right to buy)	03/22/2018(5)	03/22/2027	Common Stock	6,419	72.83	D
Employee Stock Option (right to buy)	03/28/2019(6)	03/28/2028	Common Stock	4,049	44.78	D
Employee Stock Option (right to buy)	03/27/2020(7)	03/27/2029	Common Stock	4,365	58.94	D
Employee Stock Option (right to buy)	03/25/2021(8)	03/25/2030	Common Stock	14,922	21.6	D

Explanation of Responses:

1. Represents 1,828 performance-based restricted stock units earned for the 2018-19 long term incentive period, which will vest on March 25, 2021, and are payable solely in shares of the Company's common stock, and 6,680 time- based restricted stock units awarded under the Foot Locker 2007 Stock Incentive Plan, as amended and restated, which will vest subject to the reporting person's continued employment through the vesting dates.

2. Option granted on March 26, 2014, and vested in three equal annual installments, beginning on March 26, 2015, which is the first anniversary of the date of grant.

3. Option granted on March 25, 2015, and vested in three equal annual installments, beginning on March 25, 2016, which is the first anniversary of the date of grant.

4. Option granted on March 23, 2016, and vested in three equal annual installments, beginning on March 23, 2017, which is the first anniversary of the date of grant.

5. Option granted on March 22, 2017, and vested in three equal annual installments, beginning on March 22, 2018, which is the first anniversary of the date of grant.

6. Option granted on March 28, 2018, and vests in three equal annual installments, beginning on March 28, 2019, which is the first anniversary of the date of grant.

7. Option granted on March 27, 2019, and vests in three equal annual installments, beginning on March 27, 2020, which is the first anniversary of the date of grant.

8. Option granted on March 25, 2020, and vests in three equal annual installments, beginning on March 25, 2021, which is the first anniversary of the date of grant.

	/s/ Anthony D. Foti, Attorney-in-Fact for Franklin Bracken	08/03/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that, effective as of the date hereof,
the undersigned hereby constitutes and appoints each of Sheilagh M. Clarke,
Anthony D. Foti, and Awilda Morales, signing singly, the undersigned's true
and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as a director and/or executive officer of Foot Locker, Inc.
(the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934 and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5, complete and execute any amendment or amendments thereto,
and timely file such form with the U.S. Securities and Exchange Commission
and the New York Stock Exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and conditions
as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this
Power of Attorney and the rights and powers herein granted.  The
undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities and Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect
to the undersigned's holdings of and transactions in securities issued by
the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 23rd day of July, 2020.

/s/ Franklin Bracken
Franklin Bracken